PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo StudyFu-Shun Hsu, Kuo‐How Huang, Chen-Hsun Hsu et al.|International Journal of Molecular Sciences|2021Cited by 27
The UCHL5 inhibitor b-AP15 overcomes cisplatin resistance via suppression of cancer stemness in urothelial carcinomaPo‐Ming Chow, Kuo‐How Huang, Jun-Ren Dong et al.|Molecular Therapy — Oncolytics|2022Cited by 18